Po-Kai Chuang earned a Ph.D. in Basic Medical Sciences from the National Cheng Kung University (2017). His work in glycobiology, oncology, drug-resistant cancer, antibody bioengineering, cancer stem cells, and immunotherapy.
Postdoctoral Associate, The Scripps Research Institute (2019–2023); Postdoctoral Fellow, Academia Sinica (2018–2019)
Research Expertise: Dr. Chuang specializes in glycobiology oncology, with 14 years of experience studying globo-series glycosphingolipids and their role in cancer. His research focuses on the interplay between glycans and anti-tumor immunity, chemical biology, and drug discovery.
Professional Recognition: Honorary member of Phi Tau Phi Scholastic Honor Society, R.O.C; Member of The American Society for Biochemistry and Molecular Biology; GMP Training Certificate
Po-Kai Chuang earned a Ph.D. in Basic Medical Sciences from the National Cheng Kung University (2017). His work in glycobiology, oncology, drug-resistant cancer, antibody bioengineering, cancer stem cells, and immunotherapy.
Postdoctoral Associate, The Scripps Research Institute (2019–2023); Postdoctoral Fellow, Academia Sinica (2018–2019)
Research Expertise: Dr. Chuang specializes in glycobiology oncology, with 14 years of experience studying globo-series glycosphingolipids and their role in cancer. His research focuses on the interplay between glycans and anti-tumor immunity, chemical biology, and drug discovery.
Professional Recognition: Honorary member of Phi Tau Phi Scholastic Honor Society, R.O.C; Member of The American Society for Biochemistry and Molecular Biology; GMP Training Certificate